Vistagen Therapeutics Inc (VTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2010 | 12-2009 | 12-2008 | 03-2008 | 12-2007 | |
| Operating Expenses | 9 | 22 | 16 | 16 | 5 |
| Operating Income | -9 | -22 | -16 | -16 | -5 |
| Pre-tax Income | -9 | -22 | -16 | -16 | -5 |
| Net Income Continuous | -9 | -22 | -16 | -16 | -5 |
| Net Income | $-9 | $-22 | $-16 | $-16 | $-5 |
| EPS Basic Continuous Ops | -0.05 | -0.11 | -0.09 | N/A | -0.03 |
| EPS Diluted Continuous Ops | -0.05 | -0.11 | -0.09 | N/A | -0.03 |
| EBITDA(a) | $-9 | $-22 | $-16 | $-16 | $-5 |